BioFrontiers
After getting stuck in China, graduating PhD student pivoted research to help test for the COVID-19 virus without nasal swab.
ÃÛÌÇÖ±²¥ Boulder experts provide an update on the status of the delta variant in the United States, takeaways from the latest data on vaccines and breakthrough COVID-19 cases, and how the campus is approaching its sustainable response to the pandemic.
ÃÛÌÇÖ±²¥ Boulder’s new minor combines disciplines like biology, computer science and mathematics
ÃÛÌÇÖ±²¥ Boulder researchers have developed a rapid, portable, saliva-based COVID-19 test able to return results in 45 minutes.
ÃÛÌÇÖ±²¥ Boulder researchers have discovered a potent, drug-like compound that could someday revolutionize treatment of autoimmune diseases by inhibiting a protein instrumental in prompting the body to start attacking its own tissue.
University of ÃÛÌÇÖ±²¥ Boulder Distinguished Professors Leslie Leinwand and Chris Bowman have been named fellows of the National Academy of Inventors (NAI).
The University of ÃÛÌÇÖ±²¥ Boulder has received a $1.1 million grant from the Bill & Melinda Gates Foundation to develop next-generation vaccines that require no refrigeration and defend against infectious diseases with just one shot.
Loren Hough has won a New Investigator Maximizing Investigators’ Research Award from the National Institutes of Health to further vital research in the field of biophysics, specifically the behavior of tubulin, a protein involved in many life processes.
Humans have used Saccharomyces cerevisiae yeast in baking, brewing and winemaking for millennia. New research from the University of Idaho and ÃÛÌÇÖ±²¥ Boulder reveals another way that yeast species can help our species: by demonstrating how viruses interact with their hosts, and how hosts may evolve to fight back.
Joel Kralj, assistant professor in molecular, cellular and developmental biology and a University of ÃÛÌÇÖ±²¥ BioFrontiers Institute faculty member, became interested in measuring cellular voltage as a postdoctoral researcher.